(1–3)-β-D-Glucan Assay is a test that measures the amount of β-(1, 3) glucans in serum.Industry Growth Insights published a new data on “(1–3)-β-D-Glucan Assay Market”. The research report is titled “(1–3)-β-D-Glucan Assay Market research by Types (Turbidimetric Method, Chromogenic Method, Other), By Applications (Food, Pharmaceutical, Cosmetic, Other), By Players/Companies BioVision Inc, Megazyme Ltd, Dynamiker Biotechnology (Tianjin) Co., Ltd, Tianjin Era Biology Techology Co., Ltd, Associates of Cape Cod, Inc., Charles River Laboratories International, Inc, Autobio Diagnostics Co., Ltd, Fuzhou Xinbei Biochemistry Industry Co., Ltd.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
(1–3)-β-D-Glucan Assay Market Research Report
By Type
Turbidimetric Method, Chromogenic Method, Other
By Application
Food, Pharmaceutical, Cosmetic, Other
By Companies
BioVision Inc, Megazyme Ltd, Dynamiker Biotechnology (Tianjin) Co., Ltd, Tianjin Era Biology Techology Co., Ltd, Associates of Cape Cod, Inc., Charles River Laboratories International, Inc, Autobio Diagnostics Co., Ltd, Fuzhou Xinbei Biochemistry Industry Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global (1–3)-β-D-Glucan Assay Market Report Segments:
The global (1–3)-β-D-Glucan Assay market is segmented on the basis of:
Types
Turbidimetric Method, Chromogenic Method, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food, Pharmaceutical, Cosmetic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioVision Inc
- Megazyme Ltd
- Dynamiker Biotechnology (Tianjin) Co., Ltd
- Tianjin Era Biology Techology Co., Ltd
- Associates of Cape Cod, Inc.
- Charles River Laboratories International, Inc
- Autobio Diagnostics Co., Ltd
- Fuzhou Xinbei Biochemistry Industry Co., Ltd.
Highlights of The (1–3)-β-D-Glucan Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Turbidimetric Method
- Chromogenic Method
- Other
- By Application:
- Food
- Pharmaceutical
- Cosmetic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the (1–3)-β-D-Glucan Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The (1u00e2u20acu201c3)-u00ceu00b2-D-Glucan assay is a method used to measure the amount of (1u00e2u20acu201c3)-u00ceu00b2-D-glucan in a sample. The assay uses an enzyme called u00ceu00b1-(1,4) glucan endocellulase to break down the glucans into smaller glucose molecules.
Some of the major companies in the (1–3)-î²-d-glucan assay market are BioVision Inc, Megazyme Ltd, Dynamiker Biotechnology (Tianjin) Co., Ltd, Tianjin Era Biology Techology Co., Ltd, Associates of Cape Cod, Inc., Charles River Laboratories International, Inc, Autobio Diagnostics Co., Ltd, Fuzhou Xinbei Biochemistry Industry Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 (1–3)-β-D-Glucan Assay Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 (1–3)-β-D-Glucan Assay Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 (1–3)-β-D-Glucan Assay Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the (1–3)-β-D-Glucan Assay Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global (1–3)-β-D-Glucan Assay Market Size & Forecast, 2018-2028 4.5.1 (1–3)-β-D-Glucan Assay Market Size and Y-o-Y Growth 4.5.2 (1–3)-β-D-Glucan Assay Market Absolute $ Opportunity
Chapter 5 Global (1–3)-β-D-Glucan Assay Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 (1–3)-β-D-Glucan Assay Market Size Forecast by Type
5.2.1 Turbidimetric Method
5.2.2 Chromogenic Method
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global (1–3)-β-D-Glucan Assay Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
6.2.1 Food
6.2.2 Pharmaceutical
6.2.3 Cosmetic
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global (1–3)-β-D-Glucan Assay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 (1–3)-β-D-Glucan Assay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America (1–3)-β-D-Glucan Assay Analysis and Forecast
9.1 Introduction
9.2 North America (1–3)-β-D-Glucan Assay Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America (1–3)-β-D-Glucan Assay Market Size Forecast by Type
9.6.1 Turbidimetric Method
9.6.2 Chromogenic Method
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
9.10.1 Food
9.10.2 Pharmaceutical
9.10.3 Cosmetic
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe (1–3)-β-D-Glucan Assay Analysis and Forecast
10.1 Introduction
10.2 Europe (1–3)-β-D-Glucan Assay Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe (1–3)-β-D-Glucan Assay Market Size Forecast by Type
10.6.1 Turbidimetric Method
10.6.2 Chromogenic Method
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
10.10.1 Food
10.10.2 Pharmaceutical
10.10.3 Cosmetic
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific (1–3)-β-D-Glucan Assay Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific (1–3)-β-D-Glucan Assay Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific (1–3)-β-D-Glucan Assay Market Size Forecast by Type
11.6.1 Turbidimetric Method
11.6.2 Chromogenic Method
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
11.10.1 Food
11.10.2 Pharmaceutical
11.10.3 Cosmetic
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America (1–3)-β-D-Glucan Assay Analysis and Forecast
12.1 Introduction
12.2 Latin America (1–3)-β-D-Glucan Assay Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America (1–3)-β-D-Glucan Assay Market Size Forecast by Type
12.6.1 Turbidimetric Method
12.6.2 Chromogenic Method
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
12.10.1 Food
12.10.2 Pharmaceutical
12.10.3 Cosmetic
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) (1–3)-β-D-Glucan Assay Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) (1–3)-β-D-Glucan Assay Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) (1–3)-β-D-Glucan Assay Market Size Forecast by Type
13.6.1 Turbidimetric Method
13.6.2 Chromogenic Method
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) (1–3)-β-D-Glucan Assay Market Size Forecast by Applications
13.10.1 Food
13.10.2 Pharmaceutical
13.10.3 Cosmetic
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 (1–3)-β-D-Glucan Assay Market: Competitive Dashboard
14.2 Global (1–3)-β-D-Glucan Assay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioVision Inc
14.3.2 Megazyme Ltd
14.3.3 Dynamiker Biotechnology (Tianjin) Co., Ltd
14.3.4 Tianjin Era Biology Techology Co., Ltd
14.3.5 Associates of Cape Cod, Inc.
14.3.6 Charles River Laboratories International, Inc
14.3.7 Autobio Diagnostics Co., Ltd
14.3.8 Fuzhou Xinbei Biochemistry Industry Co., Ltd.